Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Ravi Kamath

Diagnostic Radiology Fairfax, VA Medical Doctor

NPI 1518933951 CMS profile 691707

2722 Merrilee Dr, Suite 230, Fairfax, VA 22031

Open in the dashboard

General payments

$93,948

47 records reported · program years 2020–2025

Research payments

$7,013

Paid to them · 4 records reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ravi Kamath of Fairfax, VA is reported in the CMS Open Payments database as having received $93,948 across 47 general payments and $7,013 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $84,568 33
2024 Research $3,825 2
2023 General $3,080 1
2023 Research $3,188 2
2021 General $3,600 4
2020 General $2,700 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ravi Kamath
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Ravi Kamath were reported at $84,568. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Ravi Kamath Diagnostic Radiology median Middle half National median
2019 $0 $108 $29–$318 $163
2020 $2,700 $65 $21–$252 $114
2021 $3,600 $92 $24–$292 $132
2022 $0 $104 $29–$294 $149
2023 $3,080 $110 $29–$337 $160
2024 $0 $113 $30–$356 $164
2025 $84,568 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Genzyme Corporation $84,568 33 payments
  2. Intrinsic Therapeutics $6,300 13 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $3,080 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $70,312 11 payments
  2. Consulting Fee $14,847 15 payments
  3. Travel and Lodging $8,028 14 payments
  4. Food and Beverage $762 7 payments
Products named General payments · program years 2020–2025
  1. CEREZYME $70,525 31 payments
  2. CERDELGA $70,525 31 payments
  3. Barricaid Annular Closure Device Orthopedic $3,600 4 payments
  4. Barricaid Annular Closure Device Orthopedic $2,700 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2020–2025
  1. Intrinsic Therapeutics $7,013 4 payments

Billing to Medicare

Part B · data year 2024 · 117 billing codes

Paid by Medicare

$296,071

Of which drugs: $479

Medicare patients

6,034

Average age 76

Services billed

9,995

3,736 women, 2,298 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 30%
Diabetes 28%
Chronic kidney disease 25%
Depression 23%
Osteoporosis 23%
Atrial fibrillation 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadoteridol, (prohance multipack), per ml A9576 Office 18 275 $232

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

51 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record